Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Mechanism of action in thalidomide teratogenesis.

Stephens TD, Bunde CJ, Fillmore BJ.

Biochem Pharmacol. 2000 Jun 15;59(12):1489-99. Review.

PMID:
10799645
2.

Hypothesis: thalidomide embryopathy-proposed mechanism of action.

Stephens TD, Fillmore BJ.

Teratology. 2000 Mar;61(3):189-95. Review.

PMID:
10661908
3.

Thalidomide down-regulates transcript levels of GC-rich promoter genes in multiple myeloma.

Drucker L, Uziel O, Tohami T, Shapiro H, Radnay J, Yarkoni S, Lahav M, Lishner M.

Mol Pharmacol. 2003 Aug;64(2):415-20.

4.

Downregulated expression of integrin alpha6 by transforming growth factor-beta(1) on lens epithelial cells in vitro.

Lim JM, Kim JA, Lee JH, Joo CK.

Biochem Biophys Res Commun. 2001 Jun 1;284(1):33-41.

PMID:
11374867
5.

Enhanced pathological angiogenesis in mice lacking beta3 integrin or beta3 and beta5 integrins.

Reynolds LE, Wyder L, Lively JC, Taverna D, Robinson SD, Huang X, Sheppard D, Hynes RO, Hodivala-Dilke KM.

Nat Med. 2002 Jan;8(1):27-34.

PMID:
11786903
6.

The G-rich promoter and G-rich coding sequence of basic fibroblast growth factor are the targets of thalidomide in glioma.

Mei SC, Wu RT.

Mol Cancer Ther. 2008 Aug;7(8):2405-14. doi: 10.1158/1535-7163.MCT-07-2398. Epub 2008 Aug 6.

7.

A naturally occurring point mutation in the beta3 integrin MIDAS-like domain affects differently alphavbeta3 and alphaIIIbbeta3 receptor function.

Morel-Kopp MC, Melchior C, Chen P, Ammerlaan W, Lecompte T, Kaplan C, Kieffer N.

Thromb Haemost. 2001 Dec;86(6):1425-34.

PMID:
11776310
8.
9.
10.
11.
12.
13.
14.

Teratogenic effects of thalidomide: molecular mechanisms.

Ito T, Ando H, Handa H.

Cell Mol Life Sci. 2011 May;68(9):1569-79. doi: 10.1007/s00018-010-0619-9. Epub 2011 Jan 5. Review.

PMID:
21207098
15.

Fibroblast growth factor 2 induction of the osteocalcin gene requires MAPK activity and phosphorylation of the osteoblast transcription factor, Cbfa1/Runx2.

Xiao G, Jiang D, Gopalakrishnan R, Franceschi RT.

J Biol Chem. 2002 Sep 27;277(39):36181-7. Epub 2002 Aug 28.

17.

New insights into the pharmacological and toxicological effects of thalidomide.

Meierhofer C, Wiedermann CJ.

Curr Opin Drug Discov Devel. 2003 Jan;6(1):92-9. Review.

PMID:
12613280
18.
19.

Antitumor effects of thalidomide analogs in human prostate cancer xenografts implanted in immunodeficient mice.

Ng SS, MacPherson GR, G├╝tschow M, Eger K, Figg WD.

Clin Cancer Res. 2004 Jun 15;10(12 Pt 1):4192-7.

20.
Items per page

Supplemental Content

Write to the Help Desk